Savior Lifetec Corporation (4167.TWO)
TWD 16.2
(2.21%)
TWD 16.2
(2.21%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 223.36 Million TWD | -0.83% |
| 2022 | 225.24 Million TWD | -20.03% |
| 2021 | 281.66 Million TWD | -10.92% |
| 2020 | 316.2 Million TWD | 9.62% |
| 2019 | 288.45 Million TWD | 0.39% |
| 2018 | 287.33 Million TWD | -14.06% |
| 2017 | 334.35 Million TWD | -9.62% |
| 2016 | 369.95 Million TWD | -2.88% |
| 2015 | 380.93 Million TWD | 8.42% |
| 2014 | 351.35 Million TWD | 19.16% |
| 2013 | 294.85 Million TWD | 49.67% |
| 2012 | 197 Million TWD | 23.74% |
| 2011 | 159.21 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 47.51 Million TWD | -1.45% |
| 2024 Q1 | 56.92 Million TWD | 6.95% |
| 2023 Q3 | 55.57 Million TWD | -3.34% |
| 2023 Q4 | 53.22 Million TWD | -4.23% |
| 2023 FY | 223.36 Million TWD | -0.83% |
| 2023 Q1 | 58.12 Million TWD | 13.84% |
| 2023 Q2 | 57.49 Million TWD | -1.09% |
| 2022 FY | 225.24 Million TWD | -20.03% |
| 2022 Q4 | 51.06 Million TWD | -9.63% |
| 2022 Q2 | 55.42 Million TWD | -10.97% |
| 2022 Q3 | 56.5 Million TWD | 1.94% |
| 2022 Q1 | 62.25 Million TWD | 9.66% |
| 2021 Q3 | 78.71 Million TWD | 2.65% |
| 2021 Q1 | 69.49 Million TWD | -11.13% |
| 2021 FY | 281.66 Million TWD | -10.92% |
| 2021 Q2 | 76.68 Million TWD | 10.35% |
| 2021 Q4 | 56.77 Million TWD | -27.88% |
| 2020 FY | 316.2 Million TWD | 9.62% |
| 2020 Q3 | 70.93 Million TWD | -7.75% |
| 2020 Q2 | 76.89 Million TWD | -14.73% |
| 2020 Q1 | 90.17 Million TWD | 22.0% |
| 2020 Q4 | 78.19 Million TWD | 10.23% |
| 2019 Q2 | 72.29 Million TWD | 16.2% |
| 2019 Q4 | 73.91 Million TWD | -7.62% |
| 2019 Q3 | 80.01 Million TWD | 10.68% |
| 2019 FY | 288.45 Million TWD | 0.39% |
| 2019 Q1 | 62.22 Million TWD | -38.15% |
| 2018 FY | 287.33 Million TWD | -14.06% |
| 2018 Q4 | 100.6 Million TWD | 111.5% |
| 2018 Q3 | 47.56 Million TWD | -29.74% |
| 2018 Q2 | 67.7 Million TWD | -5.27% |
| 2018 Q1 | 71.47 Million TWD | -8.5% |
| 2017 FY | 334.35 Million TWD | -9.62% |
| 2017 Q3 | 89.6 Million TWD | 1.65% |
| 2017 Q1 | 78.49 Million TWD | -20.85% |
| 2017 Q2 | 88.14 Million TWD | 12.3% |
| 2017 Q4 | 78.1 Million TWD | -12.83% |
| 2016 Q4 | 99.16 Million TWD | 13.3% |
| 2016 FY | 369.95 Million TWD | -2.88% |
| 2016 Q1 | 89.78 Million TWD | -16.54% |
| 2016 Q3 | 87.52 Million TWD | -6.36% |
| 2016 Q2 | 93.47 Million TWD | 4.11% |
| 2015 Q4 | 107.58 Million TWD | 12.71% |
| 2015 Q3 | 95.45 Million TWD | 11.01% |
| 2015 FY | 380.93 Million TWD | 8.42% |
| 2015 Q2 | 85.99 Million TWD | -6.44% |
| 2015 Q1 | 91.9 Million TWD | -44.9% |
| 2014 Q3 | 59.2 Million TWD | -22.72% |
| 2014 FY | 351.35 Million TWD | 19.16% |
| 2014 Q4 | 166.8 Million TWD | 181.76% |
| 2014 Q2 | 76.6 Million TWD | -11.31% |
| 2014 Q1 | 86.37 Million TWD | -3.7% |
| 2013 Q1 | 67.35 Million TWD | 29.66% |
| 2013 Q4 | 89.68 Million TWD | 14.65% |
| 2013 FY | 294.85 Million TWD | 49.67% |
| 2013 Q3 | 78.23 Million TWD | 16.15% |
| 2013 Q2 | 67.35 Million TWD | 0.0% |
| 2012 Q2 | - TWD | 0.0% |
| 2012 FY | 197 Million TWD | 23.74% |
| 2012 Q4 | 51.94 Million TWD | 0.0% |
| 2012 Q3 | 51.94 Million TWD | 0.0% |
| 2011 Q4 | - TWD | 0.0% |
| 2011 FY | 159.21 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | -74.958% |
| Level Biotechnology Inc. | 151.99 Million TWD | -46.96% |
| Sagittarius Life Science Corp | 135.85 Million TWD | -64.42% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | -194.453% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 0.828% |
| GlycoNex Incorporation | 995 Thousand TWD | -22349.146% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | 13.042% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | -15.028% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | -385.342% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | -86.281% |
| Visgeneer Inc. | 67.48 Million TWD | -231.005% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 159.535% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 56.21% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | -249.544% |
| Neith Corporation | 66.87 Million TWD | -234.02% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 84.532% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -661.001% |
| Enimmune corporation | 220.1 Million TWD | -1.484% |
| TaiRx, Inc. | 217.13 Million TWD | -2.871% |
| EirGenix Inc. | 236.74 Million TWD | 5.648% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | -114.055% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | 37.54% |
| Lin BioScience, Inc. | 1.09 Billion TWD | 79.635% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 16.077% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | -351.515% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -20525.023% |
| Lukas Biomedical Inc. | 177.45 Million TWD | -25.877% |
| RBC Bioscience Corporation | 58.35 Million TWD | -282.77% |
| BiOptic Inc. | 108.69 Million TWD | -105.506% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -248087.778% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | -222.089% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -8441.836% |
| VBI | 32.55 Million TWD | -586.128% |
| CHO Pharma, Inc. | 268.99 Million TWD | 16.963% |
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -67793.313% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 65.311% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | -139.317% |
| NaviFUS Corp. | 11.82 Million TWD | -1788.636% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | -17.113% |
| Sinew Pharma Inc. | 186.25 Million TWD | -19.928% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | -201.756% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | -1.348% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | -438.485% |
| AP Biosciences Inc | 32.25 Million TWD | -592.553% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 87.929% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -4135.286% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | 29.609% |
| Intech Biopharm Corporation | -163.99 Million TWD | 236.205% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 80.219% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | -438.472% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | -31.738% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | -51.929% |
| TCI GENE Inc. | 174.61 Million TWD | -27.919% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -1240838.889% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | 25.776% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 23.23% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | -166.09% |
| PharmaEngine, Inc. | 441.78 Million TWD | 49.44% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 13.683% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 88.922% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | -60.848% |
| Acepodia, Inc. | 452.56 Million TWD | 50.644% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 58.707% |